|
HS Code |
847431 |
| Product Name | 4-Bromo-3,5-Dimethylisoxazole |
| Cas Number | 32884-18-7 |
| Molecular Formula | C5H6BrNO |
| Molecular Weight | 176.01 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 62-65 °C |
| Purity | Typically ≥98% |
| Solubility | Soluble in organic solvents such as DMSO, methanol, and ethanol |
| Smiles | CC1=NC(C)=C(Br)O1 |
| Inchi | InChI=1S/C5H6BrNO/c1-3-5(6)9-4(2)7-3/h1-2H3 |
| Storage Conditions | Store at 2-8°C, tightly closed |
As an accredited 4-Bromo-3,5-Dimethylisoxazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 4-Bromo-3,5-Dimethylisoxazole, sealed with a tamper-evident cap and labeled for laboratory use. |
| Shipping | 4-Bromo-3,5-Dimethylisoxazole is shipped in tightly sealed containers, protected from light and moisture. It is transported according to local and international chemical safety regulations, usually as a non-hazardous solid. Appropriate labeling and documentation accompany the shipment to ensure safe handling, regulatory compliance, and quick identification upon delivery. |
| Storage | 4-Bromo-3,5-Dimethylisoxazole should be stored in a cool, dry, and well-ventilated area, away from sources of ignition and incompatible substances such as strong oxidizers. Keep the container tightly closed when not in use, protected from moisture and direct sunlight. Store under inert atmosphere if possible to prevent decomposition, and always follow standard laboratory chemical storage protocols. |
Applications of 4-Bromo-3,5-Dimethylisoxazole in Industrial Manufacturing4-Bromo-3,5-Dimethylisoxazole serves multiple roles in chemical synthesis, especially for fine chemicals, pharmaceuticals, and agrochemicals. As a manufacturer, we ensure precision and regulatory alignment for each industrial application through close collaboration with downstream plants and strict process controls. 1. Pharmaceutical Intermediate for CNS Active CompoundsThis compound functions as a crucial intermediate in the synthesis of active pharmaceutical ingredients targeting the central nervous system, particularly in the development of novel anticonvulsant and antidepressant drugs. Its structural motif enables specific heterocyclic transformations required for proprietary CNS drug candidates. Process chemists utilize this intermediate during key heteroaromatic construction and late-stage substitutions in multi-step synthesis under GMP conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis for Isoxazole-Based FungicidesDownstream agrochemical manufacturers deploy this compound in the multi-step synthesis of isoxazole-functionalized fungicidal actives. Its role as a building block enables selective ring substitution critical to binding-site specificity in innovative crop protection agents. Detailed substrate reactivity knowledge helps formulation chemists optimize reaction yields and purity under agrochemical GMP protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom Synthesis for Performance Polymer AdditivesChemical plants utilize this material in the custom synthesis of polymer additives, specifically as a precursor for tailor-made UV stabilizers and flame retardants. Proper attention to isoxazole reactivity allows precise functional group incorporation, enabling downstream manufacturers to develop specialty resins for critical infrastructure and automotive interiors. Manufacturing emphasizes pure feedstock and minimal residual halide content for downstream polymer compatibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Electronic Material DevelopmentMaterials scientists and semiconductor firms incorporate this compound in the synthesis of heterocyclic ligand precursors for electronic materials, especially in the field of organic field-effect transistors (OFETs) and OLEDs. The methyl and bromo substituents allow for highly selective coupling and controlled doping. Precise specifications and low metal content fulfill downstream traceability and batch consistency requirements for critical electronics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Building Block for Specialty Chemical ResearchUniversity laboratories and R&D companies regularly use this material as a core building block for synthesizing novel heterocyclic frameworks. Its unique substitution pattern grants access to tailored small molecule probes and ligands in medicinal chemistry and catalysis. High-purity grade and detailed certificates of analysis satisfy grant and publication requirements, while flexible delivery formats support scale-up experiments and structure-activity relationship studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-3,5-Dimethylisoxazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Talking about specialty chemicals, 4-Bromo-3,5-Dimethylisoxazole stands out as a reliable intermediate where precision and purity matter. Through years of chemical manufacturing, we’ve learned that small differences in isoxazole structure lead to major changes for customers looking to push boundaries in pharmaceuticals, materials science, and agrochemical development. This compound, with its unique bromine and methyl substitution, highlights both the elegance and complexity of synthetic building blocks.
In our lab, the process starts with a deep respect for the reaction sequence. Each batch of 4-Bromo-3,5-Dimethylisoxazole reflects countless hours of process optimization, troubleshooting, and real-time analysis. Purity isn’t just a selling point; it’s the direct result of careful distillation, repeated crystallizations, and ongoing checks for unwanted isomers or side products. We track every impurity, cross-reference chromatography results, and keep comprehensive documentation for traceability. Customers expect consistency from one pail to the next, regardless of order size or end use.
Listening to formulation chemists and R&D partners, feedback lands on our production floor in straightforward terms: keep the batch-to-batch variance minimal and the handling straightforward. In practice, this means our 4-Bromo-3,5-Dimethylisoxazole comes as pale yellow to off-white crystalline solid, a visual cue that tells seasoned chemists about the process cleanliness before they ever run the first analysis.
Choosing to focus on practical, usable material properties, we put attention on the details that matter most for process development or scale-up. Typical product arrives with an assay of at least 98%, a moisture content well below 0.5%, and particle size that flows well during transfer and mixing. Our internal GC and NMR checks back up each lot, and these aren’t just numbers for a paper trail—they have direct impact on your yields, purification steps, and reactivity downstream.
Heat sensitivity can create hiccups for anyone unfamiliar with halogenated isoxazoles, which encouraged us early on to develop logistics and packaging that keep out air and moisture. Product comes double-lined in sealed drums: not just for shelf life, but for preventing subtle degradation that shows itself in longer reaction times or stubborn byproducts. Over years, we’ve learned which storage rooms and transit routes introduce invisible threats to material quality, and we work those risks right out of our process.
Compared with lighter analogs, the presence of bromine on this molecule adds both weight and reactivity, making it a workhorse for producing more complex drug candidates or specialty polymers. Process technicians want to see each lot behave the same whether split across multiple reactors or pushed through pilot-scale validation. Consistency doesn’t come by accident—it comes from tight protocols, employee training, and process controls.
Not all isoxazoles serve the same laboratory function, and substituent effects can make or break a synthesis. The bromine on 4-Bromo-3,5-Dimethylisoxazole offers chemists a leaving group for cross-coupling reactions such as Suzuki and Stille, setting it apart from the parent 3,5-dimethylisoxazole, which lacks sites for simple substitution. We’ve collaborated with research teams who swapped out chlorine for bromine, only to find the reactivity profiles and yields change dramatically. There’s no substitute for real-world feedback—what works in a reference paper may fall flat if the raw material veers from expected properties.
We never treat two different bromo-isoxazoles interchangeably. Minute adjustments in methyl group positions change solubility and melting point, and those physical properties determine whether a chemical fits tightly into existing plant equipment or causes bottlenecks. Our technical team routinely supports process transfer, and we provide actual batch data rather than third-party summaries. The difference comes in details: melting point checks, flowability tests, and the ease of filtering product slurries at scale.
Knowing this, we tailor our drying and sieving to maintain a narrow particle size distribution. Some competitors cut corners for volume at the expense of reproducibility. Our experience shows that end users who tolerate off-specification lots eventually run into trouble in multi-step syntheses. Feedback from the market drives us to tighten our controls, not the other way around.
4-Bromo-3,5-Dimethylisoxazole found its mainstay applications in pharmaceutical research, especially as a precursor for heterocyclic drug candidates. Medicinal chemists trust this building block for late-stage bromine substitution, which opens pathways to molecules with improved potency or metabolic stability. We’re in regular contact with researchers who need enough material for screening runs without the risks tied to continuously changing specifications.
Polymer chemists see value thanks to the dual methyl groups, which reduce side reactions and increase processability for specialty resins. In agricultural labs, the structure lets researchers test new crop protection agents with both environmental stability and targeted biological activity.
We understand that the quality demands for pilot-scale pharma batches differ from the needs of early compound screenings. So, we adjust our packaging, labeling, and sampling protocols. Customers in pharma require line-of-sight back to every starting material, and they’ll reject lots that don’t clear narrow analytical windows. Researchers in other industries, like materials science, look for long-term shelf stability and ease of handling under warehouse conditions.
Even with these differences, all users benefit from material that behaves predictably through every step. That means investing in proper solvent drying, using inert gas blanketing, and maintaining recordkeeping on every process variable. We are proud to say that repeat orders almost always come from satisfied process chemists who discovered fewer purification headaches or troubleshooting calls after switching supply to our factory.
Scaling a new compound from flask to production tank brings its own hurdles. Early in our business, we tracked dozens of small failures during process transfers, from shifts in yield caused by ambient humidity to filtration issues in winter months. We learned that quality management starts with sourcing—buying poor grade starting materials guarantees headaches down the road. We test every drum upon receipt, keep backup samples on retest cycles, and won’t hesitate to stop a run if even minor safety questions arise.
You can’t separate the chemistry from the business realities. The supply chain for halogenated materials can get tight without warning: port backups, new regulations around hazardous shipments, and seasonality in demand all put pressure on raw material prices and delivery timelines. We invested early in local waste treatment, solvent recovery lines, and robust supplier qualification to make sure customers aren’t caught short during a spike in global demand.
Long-term relationships with catalyst suppliers and packaging partners let us plan batches well ahead, smoothing out the inevitable bumps when a single link in the chain slows. We don't rely on brokers to track this for us. Our production team builds contingency plans into every batch campaign, from double-checking logistics to renting extra storage if warehouses start to fill up in peak months. Customers looking to scale up fast appreciate blunt answers about lead times, risks, and realistic batch sizes rather than empty promises.
The real stories of working with 4-Bromo-3,5-Dimethylisoxazole happen on the plant floor. Everyone—from plant manager to the technician sampling each drum—knows the responsibility that comes with halogenated intermediates. A tight process for handling, monitoring, and disposal means fewer surprises for customers and the environment alike.
We built in training programs years ago, using close feedback from experienced operators to fine-tune every handling instruction. Proper PPE, real-time air quality monitors, and quick reporting channels for off-normal events keep things safe. Any process improvement, no matter how small, that reduces manual handling or open transfers gets quick approval. From drum unloading to reactor charging, everyone follows written steps backed by hands-on observations.
Halogenated compounds can’t just be flushed or incinerated like ordinary chemicals. We invest in closed-loop solvent recovery, on-site neutralization tanks, and detailed recordkeeping for every kilogram that leaves the premises. Customers, especially multinationals bound by regulatory rules, find value in this: waste tracking, emission controls, and batch documentation cut risks of compliance violations later on. Even in markets where regulation feels less strict, these controls build trust and allow for easier audits or batch recalls if needed.
No single process holds up forever. Every batch delivers lessons for the next, often based on application feedback. One customer’s need for tighter color specs led us to optimize our filtration sequence. Another required documentation that traces every key reagent, pushing us to upgrade recordkeeping and add certificate of analysis review checkpoints. Both helped us grow stronger and reduced headaches for everyone down the line.
Tough customers improve our offering. We take every complaint seriously, whether it’s a minor caking issue during storage or a request for alternate packaging. We have swapped out liners, upgraded labeling, and changed drying cycles all based on reports from the people actually using the material. Our technical team keeps a running log of process changes, connecting supplier lot numbers to finished batches, and making all that data available for customer review.
Collaboration doesn’t stop once the material leaves the gate. We encourage customers to share real use data: how did the product behave in a new synthesis, what was the ease of recovery, what yield differences showed up at pilot scale? Each field report feeds into our own process troubleshooting. Sometimes this means running test batches under simulated customer conditions, other times it’s about auditing our own storage procedures after a customer notes color shifts after extended transit.
Having a direct line between plant staff and end users—no middlemen in the chain—shortens time to resolution. We keep detailed logs for every interaction, from technical advice during scale-up to post-delivery support.
Over the past decade, the regulatory bar has climbed. We work with compliance teams who want original analytical traces, not secondary certifications. Our quality suite uses both HPLC and GC-MS equipment capable of low ppb detection limits, ensuring each lot matches customer and agency expectation for purity, residual solvents, and trace contaminants.
We only implement new analytical methods once they have run for months on full-scale batches, because we know that changing a key measurement can ripple through an entire operation. Post-2018, we've seen more audits, more requests for documentation, and greater insistence on original raw data files. Customers in the pharmaceutical industry, especially those seeking regulatory submissions, care about spectral data, impurity profiles, and long-term batch stability.
Cleaning validation, retention sample programs, and full chain-of-custody documentation became standard, not premium. We don’t wait for regulators to push us to do these things. We noticed early on that customers with the tightest documentation needs are often the most loyal—they return not because the price is lowest, but because their own review times fall when every batch arrives with data that matches promise.
We keep up with global substance inventories, work with the best reference standards, and make sure every package label tells the real story: source batch, manufacture date, and testing protocol.
Too many suppliers claim tight quality without showing their work. Over and over, we’ve taken on new customers frustrated by inconsistent particle size or unexplained color changes that wreck their downstream yields. When our team agrees to a quality standard, we make sure each operator knows what that means, add checks along the chain, and put time into validating every new cleaning cycle or piece of equipment.
Our commitment emerges from a simple principle: If you catch problems early, you rarely let poor-quality material reach anyone who might build life-saving drugs or protective coatings with it. We document every process tweak, keep transparency lines open, and prioritize real improvements over marketing claims.
Few things matter more than building trust batch by batch, responding fast to quality issues, and never taking short-term savings over long-term reliability. End users value consistent supply, honest feedback, and the ability to scale without constant troubleshooting. Each drum we ship tells our whole plant’s story—of process learning, customer partnership, and continuous improvement.
Purchasing 4-Bromo-3,5-Dimethylisoxazole direct from a dedicated manufacturer means you get not just a chemical, but a partner committed to the realities of your workflow. We know this compound inside and out—not from a data sheet, but from boots-on-the-ground experience in both production and technical support.
Customers who value speed, reliability, and direct support find this connection matters more as projects get complex. The path from raw material to finished innovation is filled with hurdles, but tight quality control, robust documentation, and clear lines of communication take some of the unpredictability out of the process.
Over the years, we’ve earned our place not by being the largest, but by never forgetting what it’s like to be on the receiving end of a new material: Will it work as planned? Is there backup support when a new hurdle appears? Our answer remains constant. We build every gram, check every batch, and stand behind the material until you can stand behind your end product.
4-Bromo-3,5-Dimethylisoxazole carries both technical promise and practical realities. From our manufacturing floor to your research bench, we focus on making sure both align.